Your browser doesn't support javascript.
loading
Measuring the value of solidarity: The abem financial assistance program for out-of-pocket payments on pharmacy medicines in Portugal.
Gouveia, Miguel; Borges, Margarida; Costa, João; Lourenço, Francisco; Fiorentino, Francesca; Rodrigues, António Teixeira; Teixeira, Inês; Guerreiro, José Pedro; Caetano, Patrícia; Carneiro, António Vaz.
Afiliação
  • Gouveia M; Associate Professor, Catolica Lisbon School of Business and Economics, Lisbon, Portugal.
  • Borges M; Director, Center for Evidence-Based Medicine, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
  • Costa J; Director, Center for Evidence-Based Medicine, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
  • Lourenço F; Researcher, Center for Evidence-Based Medicine, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
  • Fiorentino F; Researcher, Center for Evidence-Based Medicine, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
  • Rodrigues AT; Director, Centre for Health Evaluation & Research, National Association of Pharmacies, Lisbon, Portugal.
  • Teixeira I; Senior Researcher, Centre for Health Evaluation & Research, National Association of Pharmacies, Lisbon, Portugal.
  • Guerreiro JP; Senior Researcher, Centre for Health Evaluation & Research, National Association of Pharmacies, Lisbon, Portugal.
  • Caetano P; Researcher, Centre for Health Evaluation & Research, National Association of Pharmacies, Lisbon, Portugal.
  • Carneiro AV; Director, Institute for Preventive Medicine and Public Health, Lisbon, Portugal.
J Health Serv Res Policy ; 29(1): 4-11, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37596777
ABSTRACT

OBJECTIVE:

Out-of-pocket payments for prescribed medicines are still comparatively high in Portugal. The abem program was launched in Portugal in May 2016 to aid vulnerable groups by completely covering out-of-pocket costs of prescribed medicines in community pharmacies. This study assesses the impact of the program on poverty and catastrophic health expenditures.

METHODS:

A longitudinal study was carried out with the analysis of several program databases (from the beginning of the program in May 2016 to September 2018) covering the cohorts of beneficiaries, daily data on medicines dispensed, social referencing entities, and solidarity pharmacies. The study provides estimates of standard poverty measures (intensity and severity) as well as the incidence of catastrophic health expenditures.

RESULTS:

More than 6000 beneficiaries were supported (56.8% female, 34.7% aged 65 or over), encompassing 127,510 medicines (mainly nervous system and cardiovascular system) with an average 26.9% co-payment (payments totalling €1.5 million). The program achieved substantial reductions in poverty (3.4% in intensity, 5.6% in severity), and eliminated cases with catastrophic health expenditures in medicines that would have affected 7.5% of the beneficiaries.

CONCLUSIONS:

Findings confirm a continuous increase in the number of beneficiaries, enabling access to medicines especially for the vulnerable elderly, and a sizable impact on eliminating out-of-pocket payments for medicines in the target population.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmácia / Gastos em Saúde Tipo de estudo: Health_economic_evaluation / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmácia / Gastos em Saúde Tipo de estudo: Health_economic_evaluation / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article